Literature DB >> 1756491

Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement?

P H Fitzgerald1, C M Morris.   

Abstract

Joining of the BCR and ABL genes is an essential feature of the group of human leukemias characterized by the Philadelphia chromosome and there is recent evidence that the human BCR-ABL fusion gene induces leukemia in experimental animals. Joining of these two genes is the result of cytogenetic translocation, usually the t(9;22)(q34;q11), but sometimes of more complex translocations involving one or more chromosomes in addition to chromosomes 9 and 22. The leukemic cells of some patients carry the BCR-ABL fusion gene but have an apparently normal karyotype. Recent studies show that these cells conceal complex chromosome rearrangements. Because the BCR-ABL fusion gene appears to be the result of cytogenetic rearrangement in all cases of these leukemias, the causes and mechanism of chromosome rearrangement will be relevant to the development of leukemia in man. We examine mechanisms of chromosome rearrangement and propose that both simple and complex chromosome translocations result from a single, though sometimes complex, interchange event.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756491     DOI: 10.1016/0165-4608(91)90145-k

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Novel four-way Ph translocation t(9;22;7;1)(q34;q11;q22;p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy.

Authors:  Zámečníkova Adriana; Soad Al Bahar
Journal:  Int J Hematol       Date:  2012-02-10       Impact factor: 2.490

2.  Novel complex translocation involving 5 different chromosomes in a chronic myeloid leukemia with Philadelphia chromosome: a case report.

Authors:  Walid Al Achkar; Abdulsamad Wafa; Hasmik Mkrtchyan; Faten Moassass; Thomas Liehr
Journal:  Mol Cytogenet       Date:  2009-11-09       Impact factor: 2.009

3.  Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.

Authors:  Francesco Albano; Luisa Anelli; Antonella Zagaria; Nicoletta Coccaro; Paola Casieri; Antonella Russo Rossi; Laura Vicari; Vincenzo Liso; Mariano Rocchi; Giorgina Specchia
Journal:  Mol Cancer       Date:  2010-05-25       Impact factor: 27.401

4.  BCR translocation to derivative chromosome 2: a new case of chronic myeloid leukemia with a complex variant translocation and Philadelphia chromosome.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Suher Almedani
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

5.  Complex translocation involving four chromosomes in a novel Philadelphia-positive chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Thomas Liehr
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

6.  A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report.

Authors:  Sho Yokota; Yuichi Nakamura; Masami Bessho
Journal:  Mol Cytogenet       Date:  2012-05-01       Impact factor: 2.009

Review 7.  Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia.

Authors:  Adelina Fernandes; Naranie Shanmuganathan; Susan Branford
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

8.  New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11).

Authors:  Abdeljabar El Andaloussi; Chrystele Bilhou-Nabera
Journal:  J Biomed Biotechnol       Date:  2007

9.  Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

Authors:  Andreas Hochhaus; Franҫois-Xavier Mahon; Philipp le Coutre; Ljubomir Petrov; Jeroen J W M Janssen; Nicholas C P Cross; Delphine Rea; Fausto Castagnetti; Andrzej Hellmann; Gianantonio Rosti; Norbert Gattermann; Maria Liz Paciello Coronel; Maria Asuncion Echeveste Gutierrez; Valentin Garcia-Gutierrez; Beatrice Vincenzi; Luca Dezzani; Francis J Giles
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-21       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.